Malpica Opthalmic Photography Inc is categorized under Medical Photography and Art in Haledon, NJ and active since 1986.
Malpica Opthalmic Photography Inc was established in 1986, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Photography and Art business, which does work in the B2C market, and is classified as a Medical Photography and Art, under code number 541922 by the NAICS.
If you are seeking more information, feel free to contact Erik Malpica at the company’s single location by writing to 145 Tamboer Drive, Haledon, New Jersey NJ 07508 or by phoning (973) 238-1880. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Malpica Opthalmic Photography Inc |
Contact Person: | Erik Malpica |
Address: | 145 Tamboer Drive, Haledon, New Jersey 07508 |
Phone Number: | (973) 238-1880 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1986 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Photography and Art |
SIC Code: | 8099 |
NAICS Code: | 541922 |
Share This Business: |
Malpica Opthalmic Photography Inc was started in 1986 to provide professional Medical Photography and Art under the SIC code 8099 and NAICS code 541922. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Erik Malpica for inquiries that concern Malpica Opthalmic Photography Inc by calling the company number (973) 238-1880, as your correspondence is most welcome. Additionally, the physical location of the single location of Malpica Opthalmic Photography Inc can be found at the coordinates 40.968019,-74.186016 as well as the street address 145 Tamboer Drive in Haledon, New Jersey 07508.
For its online presence, you may visit Malpica Opthalmic Photography Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.